Login / Signup

Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents.

Sunjae BaeJiYoon B AhnKMDCorey JosephRyan WhislerMark A SchnitzlerKrista L LentineBernard S KadoshDorry L SegevMara A McAdams-DeMarco
Published in: Journal of the American Society of Nephrology : JASN (2023)
Real-world evidence supports statin therapy for reducing all-cause mortality in KT recipients. Effectiveness might be greater when combined with mTOR inhibitor-based immunosuppression.
Keyphrases
  • cardiovascular disease
  • randomized controlled trial
  • systematic review
  • cell proliferation
  • coronary artery disease
  • kidney transplantation
  • type diabetes
  • low density lipoprotein